Responsive image

Register for this Webinar

Thursday, 7 May
15:00 CET - 09:00 ET

Dr. Ike K. Ahmed
Canada
Chair

Dr. I. Paul Singh
USA

Prof. Philippe Denis
France

Prof. Julián García-Feijoó
Spain

Learning Objectives:

  • Learn about existing MIGS options for the treatment of glaucoma, and gain insight into new devices currently in clinical stage development.
  • Understand the science behind the supraciliary outflow pathway, and identify the advantages of targeting the supraciliary space to reduce pressure.
  • Discover the novel MINIjectTM supraciliary device, and analyse short and longer-term clinical results in 2 prospective, multi-centre trials.

Agenda

Where do we stand with MIGS?

Dr. Ike K. Ahmed (Canada)

How can we leverage the power of the supraciliary space?

Dr. I. Paul Singh (USA)

The MINIjectTM next-generation supraciliary device

Dr. Ike K. Ahmed (Canada)

Results of STAR-I trial at 24 months

Prof. Philippe Denis (France)

Results of European STAR-II trial at 6 months

Prof. Julián García-Feijoó (Spain)

Next steps

Dr. Ike K. Ahmed (Canada)

Q&A

Registration

MINIjectTM is for clinical investigation use only and is not yet available for sale.

Scientific presentations intended for healthcare professionals only.

© Copyright - iSTAR Medical